Chris McClain is the Senior Vice President of Sales and Business Development for Be The Match BioTherapies®. He leads the Sales and Business Development team.
His team engages with cell and gene therapy companies developing innovative, life-saving therapies that can leverage the cell sourcing, cell therapy supply chain, research support and outcomes tracking capabilities of the National Marrow Donor Program®/Be The Match®.
Before joining Be The Match BioTherapies, Chris was co-Founder of Nora Therapeutics, Inc., a venture-backed biopharmaceutical company developing novel therapies in areas of significant unmet medical need in reproductive health. While at Nora Therapeutics, Chris and his team raised more than $50 million in venture capital to fund pre-clinical and clinical development of Nora’s lead asset and build out a world-class executive team.
Prior to founding Nora Therapeutics, Chris held a variety of management consulting and operational roles in the technology sector.
He has served as an advisory member of the University of Minnesota Office for Technology Commercialization Venture Center, a guest lecturer in the Life Sciences program at the University of Minnesota’s Carlson Graduate School of Management, a mentor to the annual MNCup startup competition, and a co-chair of Medical Alley’s Biotech Shared Interest Group.
Chris earned his Master of Business Administration and Bachelor of Arts in Economics from the University of California, Berkeley